#United States #Class Action #Los Angeles #Securities Fraud #Inspire Medical

Inspire Medical Systems, Inc. Shareholders: A Chance to Act

Inspire Medical Systems, Inc. (NYSE: INSP) has found itself at the center of a potential class action lawsuit, providing an opportunity for investors who suffered financial losses to take legal action. The law firm Glancy Prongay & Murray LLP has announced that shareholders may be able to lead the securities fraud lawsuit against the company, focusing on claims that were not disclosed regarding its business operations.

Background of Inspire Medical Systems

Founded to innovate within the healthcare space, Inspire Medical Systems specializes in devices aimed at treating obstructive sleep apnea (OSA). However, the company's recent performance has raised questions, particularly regarding the launch of its new Inspire V device and the handling of significant inventory levels that seemed to contradict positive public statements made by the company's leadership.

Details of the Allegation

The class action lawsuit revolves around claims that occurred between August 2024 and August 2025. Allegations against Inspire include:
1. Poor Demand for Inspire V: Documentation suggests that the demand for the Inspire V device was notably weak, as many healthcare providers are reported to have been holding large amounts of surplus inventory and displayed hesitance to adopt the new treatment protocol.
2. Incomplete Customer Training: It has been alleged that Inspire failed to adequately complete training and onboarding procedures for numerous treatment centers that were expected to utilize the device, potentially leading to operational inefficiencies.
3. Failures in IT Infrastructure and Insurance Claims: Among the critical issues claimed are the lack of established IT systems, necessary for processing customer approvals and claims, as well as the absence of necessary Medicare reimbursements at the device's launch time.

As a result of these claims, it is argued that the optimistic statements from Inspire executives regarding the company's long-term health and operational success lacked a reasonable basis, which misled shareholders and led to financial losses.

Opportunity for Shareholders

For shareholders who believe they were impacted by the alleged misconduct, this lawsuit could provide a pathway to recovery. Those wishing to participate must act quickly as the lead plaintiff deadline is set for January 5, 2026.

To join, affected shareholders are encouraged to contact Glancy Prongay & Murray LLP or their chosen counsel to learn more about their legal options. Inquiries can be made through email or phone, ensuring that potential claimants provide their address and telephone details, along with the number of shares they purchased.

How to Get Involved

For further information on pursuing this case and understanding individual rights, shareholders should consider reaching out to the listed contact:

• - Charles Linehan, Esq.
• - Glancy Prongay & Murray LLP
• - 1925 Century Park East, Suite 2100, Los Angeles, CA 90067
• - Email: [email protected]
• - Phone: 310-201-9150 | Toll-Free: 888-773-9224

Shareholders are reminded that taking no action currently does not adversely affect their ability to be included in the action. They may choose to remain an absent member of the class action or engage their counsel of choice later, should they wish to do so.

This news underscores the importance of transparency and accountability within publicly traded companies and reflects the ongoing challenges faced by shareholders navigating complex investment landscapes. As this situation evolves, it will be critical for shareholders to stay informed and consider their options carefully.